US Patent Issued to The Catholic University of America on March 4 for "Bacteriophage-based artificial viruses for human genome remodeling" (District Of Columbia Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,241,080, issued on March 4, was assigned to The Catholic University of America (Washington).

"Bacteriophage-based artificial viruses for human genome remodeling" was invented by Venigalla B. Rao (Washington) and Jingen Zhu (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described is an "artificial virus" (AV) programmed with biomolecules that can enter human cells and carry out precise human genome modification. The AVs comprise: at least one viral vector, such as bacteriophage T4; at least one therapeutic molecule, such as DNA, RNA, protein and their complex; and a lipid coating. Also described is a method of human genome modification, using...